Sunmax Biotechnology Co Ltd Total Liabilities

Latest as of September 2025: NT$454.35 Million TWD ≈ $14.31 Million USD

Sunmax Biotechnology Co Ltd total liabilities. Based on the latest financial reports, Sunmax Biotechnology Co Ltd (4728) has total liabilities worth NT$454.35 Million TWD (≈ $14.31 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 4728 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Sunmax Biotechnology Co Ltd (2015–2024)

Total liabilities of Sunmax Biotechnology Co Ltd from 2015 to 2024. This chart illustrates how Sunmax Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Sunmax Biotechnology Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Sunmax Biotechnology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Sunmax Biotechnology Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Sapphire Foods India Limited
NSE:SAPPHIRE
India Rs20.39 Billion
Shanghai Yct Electronics Group Co.Ltd
SHE:301099
China CN¥2.54 Billion
Suqian Unitech Corp. Ltd. Cl A
SHG:603065
China CN¥1.60 Billion
Anhui Korrun Co Ltd
SHE:300577
China CN¥3.66 Billion
Hainan Shennong Technology Co Ltd
SHE:300189
China CN¥398.78 Million
Beijing Utour International Travel Service Co Ltd
SHE:002707
China CN¥1.71 Billion
Charter Hall Social Infrastructure REIT
AU:CQE
Australia AU$829.70 Million
CERES POWER HLDGS
F:CFJ
Germany €38.15 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Sunmax Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 4728 asset base.

Liquidity & Leverage Metrics

Sunmax Biotechnology Co Ltd Total Liabilities Ratios Explained

Sunmax Biotechnology Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.31 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sunmax Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sunmax Biotechnology Co Ltd (2015–2024)

The table below shows the annual total liabilities of Sunmax Biotechnology Co Ltd from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 NT$337.82 Million
≈ $10.64 Million
-53.91%
2023-12-31 NT$732.99 Million
≈ $23.09 Million
+56.62%
2022-12-31 NT$468.00 Million
≈ $14.74 Million
+1.64%
2021-12-31 NT$460.44 Million
≈ $14.51 Million
-3.12%
2020-12-31 NT$475.27 Million
≈ $14.97 Million
+9.05%
2019-12-31 NT$435.82 Million
≈ $13.73 Million
+296.62%
2018-12-31 NT$109.88 Million
≈ $3.46 Million
+24.56%
2017-12-31 NT$88.22 Million
≈ $2.78 Million
+109.06%
2016-12-31 NT$42.20 Million
≈ $1.33 Million
-4.81%
2015-12-31 NT$44.33 Million
≈ $1.40 Million
--

About Sunmax Biotechnology Co Ltd

TWO:4728 Taiwan Biotechnology
Market Cap
$680.35 Million
NT$21.59 Billion TWD
Market Cap Rank
#10019 Global
#304 in Taiwan
Share Price
NT$396.50
Change (1 day)
+4.62%
52-Week Range
NT$373.00 - NT$409.00
All Time High
NT$494.50
About

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.